Tarsus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
TARS Key Statistics
Stock Snapshot
With a market cap of 2.69B, Tarsus Pharmaceuticals(TARS) trades at $62.58. The stock has a price-to-earnings ratio of -55.53.
As of 2026-07-01, Tarsus Pharmaceuticals(TARS) stock has fluctuated between $62.50 and $65.82. The current price stands at $62.58, placing the stock +0.1% above today's low and -4.9% off the high.
The Tarsus Pharmaceuticals(TARS)'s current trading volume is 116.38K, compared to an average daily volume of 953.57K.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $85.25 and a 52-week low of $38.51.
In the last year, Tarsus Pharmaceuticals(TARS) shares hit a 52-week high of $85.25 and a 52-week low of $38.51.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.